AR108108A1 - Derivados biaromáticos antibacterianos con sustitución de oxetan-3-iloxi - Google Patents

Derivados biaromáticos antibacterianos con sustitución de oxetan-3-iloxi

Info

Publication number
AR108108A1
AR108108A1 ARP170100914A ARP170100914A AR108108A1 AR 108108 A1 AR108108 A1 AR 108108A1 AR P170100914 A ARP170100914 A AR P170100914A AR P170100914 A ARP170100914 A AR P170100914A AR 108108 A1 AR108108 A1 AR 108108A1
Authority
AR
Argentina
Prior art keywords
iloxi
oxetan
replacement
antibacterial
derivatives
Prior art date
Application number
ARP170100914A
Other languages
English (en)
Original Assignee
Idorsia Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Idorsia Pharmaceuticals Ltd filed Critical Idorsia Pharmaceuticals Ltd
Publication of AR108108A1 publication Critical patent/AR108108A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/53751,4-Oxazines, e.g. morpholine
    • A61K31/53831,4-Oxazines, e.g. morpholine ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/542Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Reivindicación 1: Un compuesto de fórmula (1) en donde U¹ representa N o CH, U² representa N o CH, U³ representa N o CH, con la salvedad de que, como máximo, dos de U¹, U², U³ pueden representar N al mismo tiempo; V¹ representa N o CH, V² representa N, CH o C(OH) y V³ representa N, CH o C(OH), con la salvedad de que, como máximo, dos de V¹, V² y V³ pueden representar N al mismo tiempo; la línea discontinua “- - - -” representa un enlace o está ausente; X representa CH o N; y Q representa O ó S; o una sal de este compuesto.
ARP170100914A 2016-04-14 2017-04-10 Derivados biaromáticos antibacterianos con sustitución de oxetan-3-iloxi AR108108A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IB2016052116 2016-04-14

Publications (1)

Publication Number Publication Date
AR108108A1 true AR108108A1 (es) 2018-07-18

Family

ID=58579239

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP170100914A AR108108A1 (es) 2016-04-14 2017-04-10 Derivados biaromáticos antibacterianos con sustitución de oxetan-3-iloxi

Country Status (14)

Country Link
US (1) US20200325154A1 (es)
EP (1) EP3442970A1 (es)
JP (1) JP2019511551A (es)
KR (1) KR20180134380A (es)
CN (1) CN108884088A (es)
AR (1) AR108108A1 (es)
AU (1) AU2017248785A1 (es)
BR (1) BR112018071101A2 (es)
CA (1) CA3020570A1 (es)
EA (1) EA201892278A1 (es)
MA (1) MA44663A (es)
MX (1) MX2018012558A (es)
TW (1) TW201738239A (es)
WO (1) WO2017179002A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201833120A (zh) 2017-02-17 2018-09-16 瑞士商愛杜西亞製藥有限公司 芳基噁唑啶酮抗生素化合物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0920895A8 (pt) 2008-10-07 2017-12-26 Actelion Pharmaceuticals Ltd Compostos antibióticos de oxazolidinona tricíclica
WO2014170821A1 (en) 2013-04-16 2014-10-23 Actelion Pharmaceuticals Ltd Antibacterial biaromatic derivatives
AR102256A1 (es) * 2014-10-15 2017-02-15 Actelion Pharmaceuticals Ltd Derivados biaromáticos básicos antibacterianos con sustitución de aminoalcoxi

Also Published As

Publication number Publication date
KR20180134380A (ko) 2018-12-18
EA201892278A1 (ru) 2019-04-30
CN108884088A (zh) 2018-11-23
WO2017179002A1 (en) 2017-10-19
AU2017248785A1 (en) 2018-12-06
TW201738239A (zh) 2017-11-01
CA3020570A1 (en) 2017-10-19
MX2018012558A (es) 2019-02-13
BR112018071101A2 (pt) 2019-01-29
JP2019511551A (ja) 2019-04-25
MA44663A (fr) 2019-02-20
EP3442970A1 (en) 2019-02-20
US20200325154A1 (en) 2020-10-15

Similar Documents

Publication Publication Date Title
CO2017008072A2 (es) Composición agroquímica
CY1122821T1 (el) Παραγωγα 1,3-βενζοδιοξολιου ως αναστολεις εζη1 ή/και εζη2
CL2019000325A1 (es) Composicion farmaceutica que comprende un compuesto derivado de piridona policiclico sustituido o su sal, que tiene actividad inhibidora de la endonucleasa dependiente de cap; cristal; y composicion farmaceutica que comprende dicho cristal.
CO2020014586A2 (es) Compuestos
BR112017006253A2 (pt) novos compostos
CO2022008968A2 (es) Nuevos derivados de metilquinazolinona
CY1124374T1 (el) Ενωση αρυλαζολιου και παραγοντας ελεγχου παρασιτων
AR105967A1 (es) Sales de un inhibidor de pim quinasa
AR095523A1 (es) Derivados piridin-4-ilo
EA201791467A1 (ru) Водный офтальмологический раствор
CL2019001041A1 (es) Compuestos terapéuticos y métodos para utilizarlos.
BR112018017303A2 (pt) composto tipo piridazinona ou seu sal, e herbicida compreendendo o mesmo
CL2020000376A1 (es) Compuesto pentacíclico.
CL2018001067A1 (es) Compuesto piranodipiridínico.
EA201990238A1 (ru) ФОСФОРСОДЕРЖАЩИЕ ПРОЛЕКАРСТВА СТИМУЛЯТОРОВ sGC
MX2020004842A (es) Compuestos heterociclicos antiinfecciosos y sus usos.
AR116951A1 (es) Sales cristalinas de un inhibidor de calicreína plasmática
UY34943A (es) Composiciones herbicidas que comprenden ácido 4-amino-3-cloro-5-fluoro-6-(4-cloro-2-fluoro-3-metoxifenilo)piridina-2-carboxílico o un derivado del mismo y un sulfonilaminocarboniltriazolinona.
AR108108A1 (es) Derivados biaromáticos antibacterianos con sustitución de oxetan-3-iloxi
EA201990313A1 (ru) Производное триазолопиразинона, пригодное в качестве ингибитора фдэ1 человека
CY1125039T1 (el) Νεα χρηση του ν,ν-δις-2-μερκαπτοαιθυλ ισοφθαλαμιδιου
CY1125090T1 (el) Ενωση γουανιδινης αντικαταστασης
CY1119540T1 (el) Υποκατασταθεντα απο γλυκοπυρανοσυλιο παραγωγα ινδολο-ουριας και η χρηση τους ως αναστολεις sglt
CY1123076T1 (el) Ενωσεις βενζο-ν-υδροξυ αμιδιου που εχουν αντικαρκινικη δραστikothta
AR099868A1 (es) Compuesto amida

Legal Events

Date Code Title Description
FB Suspension of granting procedure